Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Vipera ammodytes venom is the complex toxic secretion of the long-nosed viper, widely regarded as the most dangerous snake in Europe due to its potent venom and significant yield. The venom is a heterogeneous mixture of proteins and peptides, primarily dominated by secreted phospholipases A2 (sPLA2s), such as the presynaptically neurotoxic ammodytoxins, as well as snake venom metalloproteinases (SVMPs) and serine proteases (Toxins, 2011, 3(7), 718-738). These components act synergistically to induce a range of clinical manifestations, including severe local tissue damage, systemic hemorrhage, and life-threatening neurotoxicity by blocking neurotransmitter release at the neuromuscular junction (Journal of Proteomics, 2015, 126, 25-40). In clinical toxicology, the venom is the therapeutic target for antivenoms, which utilize purified antibodies to sequester and neutralize the circulating toxins. Emerging research also focuses on small-molecule inhibitors like varespladib (a PLA2 inhibitor) and metalloproteinase inhibitors to provide rapid, field-stable treatments that can mitigate the enzymatic destruction caused by the venom before hospital-based antivenom can be administered (Scientific Reports, 2020, 10, 11245).
Neutralization of toxic proteins by specific antibodies and competitive inhibition of enzymatic activity by small molecules.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Vipera ammodytes venom.